tm
Seeing Is Believing
tm
Seeing Is Believing
Ambrx Biopharma's activity chart (see below) currently has 28 price targets and 26 ratings on display.
Analysts average stock forecasts to be materialized ratio is 70.26% with an average time for these price targets to be met of 82.92 days.
Most recent stock forecast was given by from BAIRD on 16-Jan-2024. First documented stock forecast 13-Jul-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Apr-2022
$22
$-6 (-21.43%)
$22
2 years 9 months 7 days ago
(16-Jan-2024)
4/5 (80%)
$-5.68 (-20.52%)
128
Buy Since 20-Nov-2023
$15
2 years 9 months 13 days ago
(10-Jan-2024)
2/2 (100%)
$3.28 (27.99%)
45
Buy Since 14-Jun-2023
$28
$26
2 years 9 months 14 days ago
(09-Jan-2024)
2/2 (100%)
$0.45 (1.63%)
105
Hold Since 28-Feb-2022
$9
$-19 (-67.86%)
$10
2 years 11 months 9 days ago
(15-Nov-2023)
3/4 (75%)
$-0.45 (-4.76%)
121
Buy Since 31-Jul-2023
$32
$4 (14.29%)
$33
2 years 11 months 9 days ago
(14-Nov-2023)
0/3 (0%)
$22.99 (255.16%)
What is AMAM (Ambrx Biopharma) average time for price targets to be met?
Which analyst most recently updated their price target on AMAM (Ambrx Biopharma)?
Which analyst has the most public recommendations on AMAM (Ambrx Biopharma)?
Which analyst is the currently most bullish on AMAM (Ambrx Biopharma)?
Which analyst is the currently most reserved on AMAM (Ambrx Biopharma)?
